Page 86 - fbkCardioDiabetes_2017
P. 86

62                           Cardio Diabetes Medicine 2017





              imaging  modalities  available, echocardiography  is
              the method of choice in patients with suspected HF,
              for reasons of accuracy, availability, safety and cost.

              CONCLUSION:
              This article provides insights into the pathophysiolo-
              gy and diagnosis of progressive HF. Simple analysis
              of 24-h ambulatory electrocardiograms and measure-
              ment of serum sodium and creatinine levels identify
              patients at increased risk for progressive heart failure.
              SDNN a time domain variable of heart rate variability
              and eGFR, remain strong  independent predictors  of
              death due to progressive HF.These predictors refine
              risk stratification of patients who may progress to ad-
              vanced heart failure and identify patients who merit
              aggressive medical treatment or complex therapeutic
              regimes

              REFERENCES
              1.  The SOLVD Investigators (1992) Effect of enalapril on survival in patients
                 with reduced left ventricular  ejection  fractions  and congestive  heart
                 failure. N Engl J Med 327:685–691.
              2.  Singh S.N., Fisher S.G., Carson P.E., et al. (1998) Prevalence and signif-
                 icance of nonsustained ventricular tachycardia in patients with prema-
                 ture ventricular contractions and heart failure treated with vasodilator
                 therapy. J Am Coll Cardiol 32:942–947.
              3.  Teerlink J.R., Jalaluddin M., Anderson S., et al. (2000) Ambulatory ventric-
                 ular arrhythmias in patients with heart failure do not specifically predict
                 an increased risk of sudden death. Circulation 101:40–46.
              4.  Nolan J., Batin P.D., Andrews R., et al. (1998) Prospective study of heart
                 rate variability  and mortality in chronic  heart failure. Results  of the
                 United Kingdom Heart Failure Evaluation and Assessment of Risk Trial
                 (UK-Heart). Circulation 98:1510–1516.
              5.  Saul J.P., Arai Y., Berger R.D., et al. (1988) Assessment  of autonomic
                 regulation  in chronic congestive  heart failure by spectral  heart rate
                 analysis. Am J Cardiol 61:1292–1299.
              6.  Pomeranz B., Macaulay  R.J.B., Caudill  M.A., et  al. (1985) Assessment
                 of autonomic function in humans by heart rate spectral analysis. Am J
                 Physiol 248:H151–153.
              7.  Coresh J., Astor B.C., McQuillan G., et al. (2002) Calibration and ran-
                 dom variation  of the  serum  creatinine  assay  as critical  elements  of
                 using equations to estimate glomerular filtration rate. Am J Kidney Dis
                 39:920–929.



















                                                         GCDC 2017
   81   82   83   84   85   86   87   88   89   90   91